# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001055726-25-000012
Filing Date
2025-03-18
Accepted
2025-03-18 16:00:37
Documents
105
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | ino-20241231.htm iXBRL | 10-K | 1955361
2 | EX-19.1 | ino-12312024x10kex191.htm | EX-19.1 | 74159
3 | EX-21.1 | ino-12312024x10kex211.htm | EX-21.1 | 3379
4 | EX-23.1 | ino-12312024x10kex231.htm | EX-23.1 | 4925
5 | EX-31.1 | ino-12312024x10kex311.htm | EX-31.1 | 10980
6 | EX-31.2 | ino-12312024x10kex312.htm | EX-31.2 | 11181
7 | EX-32.1 | ino-12312024x10kex321.htm | EX-32.1 | 7806
13 |  | ino-20241231_g1.jpg | GRAPHIC | 460167
14 |  | ino-20241231_g2.jpg | GRAPHIC | 115780
15 |  | ino-20241231_g3.jpg | GRAPHIC | 51655
16 |  | ino-20241231_g4.jpg | GRAPHIC | 127169
| Complete submission text file | 0001055726-25-000012.txt |  | 12450086

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | ino-20241231.xsd | EX-101.SCH | 77952
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | ino-20241231_cal.xml | EX-101.CAL | 96160
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | ino-20241231_def.xml | EX-101.DEF | 379062
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | ino-20241231_lab.xml | EX-101.LAB | 925283
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | ino-20241231_pre.xml | EX-101.PRE | 646287
108 | EXTRACTED XBRL INSTANCE DOCUMENT | ino-20241231_htm.xml | XML | 1407248

Mailing Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462
Business Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462 8584103134
INOVIO PHARMACEUTICALS, INC. (Filer) CIK: 0001055726 (see all company filings)

EIN.: 330969592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14888 | Film No.: 25748097
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)